Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 20/20 | 0.67 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17899876 | 1.00 | SLC22A12 (0.67) | SLC22A12SLC22A6SLC22A11 | |
| SCHEMBL19435501 | 0.86 | SLC22A12 (0.55) | SLC22A12 | |
| SCHEMBL23129626 | 0.85 | SLC22A12 (0.57) | SLC22A12 | |
| SCHEMBL17899839 | 0.82 | SLC22A12 (0.70) | SLC22A12SLC22A6SLC22A11 | |
| SCHEMBL17899890 | 0.80 | SLC22A12 (1.00) | SLC22A12SLC22A6SLC22A11 | |
| SCHEMBL17899920 | 0.77 | SLC22A12 (0.78) | SLC22A12 | |
| SCHEMBL29441759 | 0.77 | SLC22A12 (0.78) | SLC22A12 | |
| SCHEMBL9994029 | 0.77 | SLC22A12 (0.69) | SLC22A12SLC22A6SLC22A11 | |
| SCHEMBL28387514 | 0.77 | SLC22A12 (0.67) | SLC22A12 | |
| SCHEMBL17899861 | 0.77 | SLC22A12 (1.00) | SLC22A12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11278528-B2 | Activator of peroxisome proliferator-activated receptor | NIPPON CHEMIPHAR CO., LTD. (JP) | 2022-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11278528-B2 | Activator of peroxisome proliferator-activated receptor | PPARA, PPARG, PPARD | SLC22A12 2004/4885SLC22A6 1911/4885SLC22A11 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.